USPTO serial 88146635
PICOLIFE TECHNOLOGIES, INNOVATIVE DRUG DELIVERY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAHMOUDI, MARIAM AZIZ
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PICOLIFE TECHNOLOGIES, INNOVATIVE DRUG DELIVERY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashkan Najafi
ASHKAN NAJAFI NAJAFI LAW, P.A.PO BOX 551339JACKSONVILLE, FL 32255UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer hardware and software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Downloadable scientific and medical data via the internet | ACTIVE | — |
| 010 | Medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; diabetic diagnostic medical devices; Carrying case specifically adapted for carrying diabetic supplies, namely, blood glucose meter, testing strips and also including insulin and other related apparatus; Devices for measuring blood sugar; Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Displays, monitors and controllers for medical fluid injectors, namely, computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus; Displays, monitors and controllers for medical fluid injectors, namely, computer displays and computer monitors and controllers therefor used in direct association with medical fluid injectors; Disposable bottle liners for use with medical apparatus; Electromagnetic drug delivery apparatus for medical use; Injection device for pharmaceuticals; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical cancer drug treatment; Medical apparatus and instruments for treating osteoarthritis, osteoporosis, osteotraumatic injuries, degenerative bone diseases and joint diseases; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus, namely, a spinal fusion device; Medical apparatus, namely, blood pump system for use in artificial liver support; Medical apparatus, namely, implantable ports; Medical devices, namely, tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human whole blood for the purpose of separating human blood components for use in blood transfusions and washing human red blood cells with clinical medical reagents for use in blood transfusions; Medical fluid injectors; Medical tubing for fluid delivery; Needles for medical purposes; Orthopedic device for injecting drugs into joint spaces | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PicoLife Technologies LLC
- Other trademarks owned by PicoLife Technologies LLC
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named PICOLIFE TECHNOLOGIES, INNOVATIVE DRUG DELIVERY
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 8, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 8, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 5, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 10, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 10, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 8, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 29, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 29, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 29, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 29, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 29, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 26, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 25, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2018 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 17, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 11, 2018 | NWAP | NEW APPLICATION ENTERED | — |